Introduction
The clinical oncology landscape in the United States is undergoing a significant transformation, propelled by advancements in genomics and molecular biology. These developments have led to the emergence of innovative technologies, such as Next Generation Sequencing (NGS), which is revolutionizing cancer diagnosis and treatment. According to TechSci Research, the United States Clinical Oncology Next Generation Sequencing Market was valued at USD 159.21 million in 2022 and is projected to grow at a CAGR of 9.12% from 2024 to 2028. This report delves into the key dynamics, emerging trends, and competitive landscape shaping this market.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on “United States Clinical Oncology Next Generation Sequencing Market.” - https://www.techsciresearch.com/report/united-states-clinical-oncology-next-generation-sequencing-market/20618.html
Loading comments...